title: Clinical response to ruxolitinib in CSF3R T618-mutated chronic neutrophilic leukemia.
authors.affiliation: Department of Pathology, Brady Memorial Laboratory, Yale School of Medicine, 310 Cedar Street, New Haven, CT, 06510, USA. maximilian.stahl@yale.edu.
authors.forename: Maximilian
authors.initials: M
authors.lastname: Stahl
authors.affiliation: Department of Pathology, Brady Memorial Laboratory, Yale School of Medicine, 310 Cedar Street, New Haven, CT, 06510, USA.
authors.forename: Mina L
authors.initials: ML
authors.lastname: Xu
authors.affiliation: Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.
authors.forename: David P
authors.initials: DP
authors.lastname: Steensma
authors.affiliation: Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.
authors.forename: Raajit
authors.initials: R
authors.lastname: Rampal
authors.affiliation: Department of Pathology, Brady Memorial Laboratory, Yale School of Medicine, 310 Cedar Street, New Haven, CT, 06510, USA.
authors.forename: Melissa
authors.initials: M
authors.lastname: Much
authors.affiliation: Department of Pathology, Brady Memorial Laboratory, Yale School of Medicine, 310 Cedar Street, New Haven, CT, 06510, USA.
authors.forename: Amer M
authors.initials: AM
authors.lastname: Zeidan
mesh_terms: D000368:Aged; D006801:Humans; D015467:Leukemia, Neutrophilic, Chronic / Q000188:drug therapy* / Q000235:genetics*; D008297:Male; D009154:Mutation / Q000235:genetics*; D009570:Nitriles; D011720:Pyrazoles / Q000627:therapeutic use*; D011743:Pyrimidines; D016184:Receptors, Colony-Stimulating Factor / Q000235:genetics*; D016896:Treatment Outcome
chemical_list: C517047:CSF3R protein, human; D009570:Nitriles; D011720:Pyrazoles; D011743:Pyrimidines; D016184:Receptors, Colony-Stimulating Factor; C540383:ruxolitinib